Multicentre European study for the treatment of advanced emphysema with bronchial valves

European Respiratory Journal

Volumn 39, Issue 6, 2012, Pages 1319-1325

  Ninane, Vincent ^a   Geltner, Christian ^b   Bezzi, Michela ^c   Foccoli, Pierfranco ^c   Gottlieb, Jens ^d   Welte, Tobias ^d   Seijo, Luis ^e   Zulueta, Javier J ^e   Munavvar, Mohammed ^g   Rosell, Antoni ^f   Lopez, Marta ^f   Jones, Paul W ^h   Coxson, Harvey O ⁱ   Springmeyer, Steven C ^j   Gonzalez, Xavier ^j  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b Landeskrankenhaus Natters   (Austria)

^c SPEDALI CIVILI   (Italy)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g ROYAL PRESTON HOSPITAL   (United Kingdom)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

ⁱ VANCOUVER GENERAL HOSPITAL   (Canada)

^j Spiration Inc   (United States)

more..

Author keywords

Bronchial valve therapy; Emphysema; Quantitative computed tomography; St George's Respiratory Questionnaire

Indexed keywords

ADULT; ARTICLE; ATELECTASIS; BRONCHIAL VALVE; BRONCHOSCOPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVICE SAFETY; DEVICE THERAPY; DISEASE SEVERITY; EUROPE; FEMALE; HUMAN; LUNG EMPHYSEMA; LUNG VOLUME; MALE; MEDICAL DEVICE; MEDICAL PROCEDURES; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE;

AGED; BRONCHOSCOPY; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84861853442     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00019711     Document Type: Article

References (27)

1. World Health Organization. Chronic Obstructive Pulmonary Disease Fact Sheet. www.who.int/mediacentre/factsheets/fs315/en/index.html Date last accessed: November 25, 2010. Date last updated: November 2010.
2. Halbert RJ, Natol JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
3. Rodriguez-Roisin R, Anzueto A, Bourbeau J, et al. GOLD Executive Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease, 2011. Available from: http://www.goldcopd.org/guidelines-global- strategy-fordiagnosis- management.html.
4. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
5. Naunheim KS, Wood DE, Mohsenifar Z, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006; 82: 431-443.
6. Cooper JD, Patterson GA, Sundarexan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: 1319-1330.
7. Berger RL, Wood KA, Cabral HJ, et al. Lung volume reduction surgery. A meta-analysis of randomized clinical trials. Treat Respir Med 2005; 4: 201-209.
8. Naunheim KS. Lung-volume reduction surgery: a vanishing operation? J Thorac Cardiovasc Surg 2007; 133: 1412-1413.
9. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361: 931-933.
10. Venuta F, di Giacomo T, Rendina EA, et al. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogeneous emphysema. Ann Thoracic Surg 2005; 79: 411-416.
11. Hopkinson NS, Toma TP, Hansell DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171: 453-460.
12. Springmeyer SC, Bollinger CT, Waddell TK, et al. Treatment of heterogeneous emphysema using the Spiration IBV Valves. Thorac Surg Clin 2009; 19: 247-253.
13. Hopkinson NS, Kemp SV, Toma TP, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J 2011; 37: 1346-1351.
14. Coxson HO, Nasute Fauerbach PV, Storness-Bliss C, et al. Computed tomography assessment of lung volume changes after bronchial valve treatment. Eur Respir J 2008; 32: 1443-1450.
15. Sterman DH, Mehta AC, Wood DE, et al. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration 2010; 79: 222-233.
16. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: 25-31.
17. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404.
18. Ware JE, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
19. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
20. Wood DE, McKenna RJ Jr, Yusen RD, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 2007; 133: 65-73.
21. Sciurba FC, Ernst A, Herth FJF, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363: 1233-1244.
22. Noppen N. Collateral ventilation in end-stage emphysema: a blessing or a curse for new bronchoscopic treatment approaches (or both)? Respiration 2007; 74: 493-495.
23. Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361: 449-456.
24. TashkinDP,Celli B, Senn S, et al. A4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554.
25. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
26. Krowka MJ. Effect of effort on measurement of forced expiratory volume in one second. Am Rev Resp Dis 1987; 136: 829-833.
27. Reilly J. COPD and declining FEV1 - time to divide and conquer? N Engl J Med 2008; 359: 1616-1618.